NCT05849025 A Study of Invasive Hemodynamic for MACHD Registry
| NCT ID | NCT05849025 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mayo Clinic |
| Condition | Healthy |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2023-10-16 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2023-10-16 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This research study is being done to provide comparative data to the Mayo Clinic Adult Congenital Heart Disease Registry.
Eligibility Criteria
Inclusion Criteria: * Capacity to Consent * BMI \</= 30 * Systolic BP \</= 140mmHg * Diastolic BP \</= 90 * eGFR \> 30 (within prior 3 months) to confirm kidney function * Able to undergo an MRI Exclusion Criteria: * History of Cardiovascular disease that may affect the results of the testing performed. * Any Current orthopedic limitations * Currently taking any cardiac medication * Pregnancy
Contact & Investigator
ACHD Research Program
📞 (507) 293-2565
Alexander Egbe, MBBS, MPH
PRINCIPAL INVESTIGATOR
Mayo Clinic
Frequently Asked Questions
Who can join the NCT05849025 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Healthy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05849025 currently recruiting?
Yes, NCT05849025 is actively recruiting participants. Visit ClinicalTrials.gov or contact Mayo Clinic to inquire about joining.
Where is the NCT05849025 trial being conducted?
This trial is being conducted at Rochester, United States.
Who is sponsoring the NCT05849025 clinical trial?
NCT05849025 is sponsored by Mayo Clinic. The principal investigator is Alexander Egbe, MBBS, MPH at Mayo Clinic. The trial plans to enroll 50 participants.